ENKEPHALINERGIC INVOLVEMENT--VOLUNTARY ALCOHOL DRINKING
脑啡肽能参与——自愿饮酒
基本信息
- 批准号:2044413
- 负责人:
- 金额:$ 10.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-04-01 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:alcoholic beverage consumption alcoholism /alcohol abuse blood chemistry drug interactions enkephalins gas chromatography gel electrophoresis genetic strain inhibitor /antagonist laboratory rat messenger RNA neurotransmitter receptor nucleic acid hybridization nucleic acid probes opioid receptor pituitary gland thirst regulatory center
项目摘要
The long-term objective of this research project is to determine
whether endogenous enkephalins play a major role as
neurotransmitters/neuromodulators of oral ethanol preference.
Studies will be performed to determine whether altering the
action of endogenous enkephalins changes voluntary ethanol
drinking. Specifically, we will examine: 1) the extent to which
various opioid receptor antagonists are capable of suppressing
voluntary ethanol consumption compared with the consumption of
other palatable and nonpalatable substances, 2) whether blocking
endogenous opioid receptors, prior to initial exposure to
ethanol, deters the initiation and development of voluntary
ethanol consumption, and 3) whether increasing the duration of
enkephalin action potentiates voluntary ethanol drinking. These
experiments will require the use of rats which voluntarily
consume large quantities of ethanol. Rats from two genetic
lines, which have been bred for oral ethanol preference, will
serve as subjects.
We also propose to determine whether the central enkephalinergic
system differs in rats that display different preferences for
oral ethanol. Specifically, we will determine: 1) whether
enkephalin and preproenkephalin mRNA content in discrete brain
and pituitary regions differs in ethanol-naive rats which have
been genetically selected for oral ethanol preference or
nonpreference, 2) whether chronic voluntary ethanol drinking, and
removal of ethanol following chronic consumption, alters brain
and pituitary content of enkephalins and preproenkephalin mRNA,
and 3) whether a true correlation exists between brain enkephalin
and preproenkephalin mRNA content and the amount of ethanol
voluntarily consumed during free-choice drinking. These
experiments will require the use of rats which voluntarily
consume high or low amounts of ethanol. Rats from four genetic
lines, which have been bred for oral ethanol preference or
nonpreference, will serve as subjects.
The results of the proposed studies should yield additional
information regarding the importance of the central
enkephalinergic system in mediating the reinforcing properties of
ethanol that contribute to the development and maintenance of
abnormal alcohol seeking behavior which characterize human
alcoholism.
这个研究项目的长期目标是确定
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
janice C Froehlich其他文献
janice C Froehlich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('janice C Froehlich', 18)}}的其他基金
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8610862 - 财政年份:2010
- 资助金额:
$ 10.12万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8036093 - 财政年份:2010
- 资助金额:
$ 10.12万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8230776 - 财政年份:2010
- 资助金额:
$ 10.12万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8436334 - 财政年份:2010
- 资助金额:
$ 10.12万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
7917969 - 财政年份:2010
- 资助金额:
$ 10.12万 - 项目类别:
ALCOHOL WITHDRAWAL IN RAT LINES SELECTED FOR PREFERENCE
优先选择的大鼠系中的酒精戒断
- 批准号:
6948391 - 财政年份:1995
- 资助金额:
$ 10.12万 - 项目类别:














{{item.name}}会员




